Neurogene (NGNE) Shares Outstanding (2013 - 2026)

Neurogene's Shares Outstanding (Entity) history runs 10 years deep, the most recent figure standing at $491867.0 for Q4 2023.

• Quarterly Shares Outstanding (Entity) fell 82.19% year-over-year to $491867.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $491867.0 (down 82.19% YoY) and the FY2023 annual result came in at $491867.0, down 82.19% from the prior year.
• Shares Outstanding (Entity) was $491867.0 for Q4 2023 at Neurogene, down from $2.8 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $2.8 million in Q2 2023 and bottomed at $491867.0 in Q4 2023.
• A 5-year average of $2.3 million and a median of $2.7 million in 2021 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2019 — Shares Outstanding (Entity) plunged 99.9% — and 2020, when it surged 109.85%.
• Neurogene's Shares Outstanding (Entity) stood at $1.4 million in 2019, then soared by 56.11% to $2.1 million in 2020, then surged by 30.44% to $2.8 million in 2021, then advanced by 0.33% to $2.8 million in 2022, then plunged by 82.19% to $491867.0 in 2023.
• Business Quant data shows NGNE's Shares Outstanding (Entity) at $491867.0 in Q4 2023, $2.8 million in Q3 2023, and $2.8 million in Q2 2023.